SCTX

Scribe Therapeutics Inc.

Healthcare · Biotechnology

16.20$ -3.5% vs. previous close Closing price · As of: Oct 5, 2026

Statements

Income Statement

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Income Statement SCTX
Line item	2024	2025
Revenue	1.56	2.91
Research & Development	3.25	3.46
Selling, General & Administrative	0.75	0.94
Total Operating Expenses	4.00	4.39
Operating Income	-2.44	-1.48
Interest Expense	0.14	0.14
Pre-Tax Income	-2.14	-1.34
Net Income	-2.72	-1.24
EBITDA	-1.84	-1.03

Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.